P&G's Billion-Dollar Deal Sparks Fears Over Supplement Quality

Procter & Gamble's $3.8 billion acquisition of Thorne has raised concerns about the quality and independence of supplements.

Thorne spent four decades building credibility with practitioners, athletes, and consumers who value transparency in their products.

The company's certificates of analysis were a key factor in this trust-building process.

Now that Thorne is owned by Procter & Gamble, some worry about the potential erosion of quality and independence.